| Followers | 131 |
| Posts | 15004 |
| Boards Moderated | 0 |
| Alias Born | 06/04/2018 |
Thursday, January 17, 2019 1:06:25 PM
News: $BDX BD Announces Preliminary Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance
FRANKLIN LAKES, N.J. , Jan. 17, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported preliminary financial results for the first fiscal quarter ended December 31, 2018. Subject to the completion...
Read the whole news https://marketwirenews.com/news-releases/bd-announces-preliminary-results-for-2019-first-fiscal-quarter-reaffirms-fiscal-2019-guidance-6995626.html
FRANKLIN LAKES, N.J. , Jan. 17, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported preliminary financial results for the first fiscal quarter ended December 31, 2018. Subject to the completion...
Read the whole news https://marketwirenews.com/news-releases/bd-announces-preliminary-results-for-2019-first-fiscal-quarter-reaffirms-fiscal-2019-guidance-6995626.html
Recent BDX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2026 12:39:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 05:41:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/26/2026 08:47:27 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/22/2026 05:24:24 PM
- Form CERT - Certification by an exchange approving securities for listing • Edgar (US Regulatory) • 05/21/2026 05:18:51 PM
- BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System • PR Newswire (US) • 05/21/2026 10:50:00 AM
- Form 8-A12B - Registration of securities [Section 12(b)] • Edgar (US Regulatory) • 05/20/2026 09:12:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 09:05:06 PM
- Peter Menziuso Named EVP and President, BD Interventional • PR Newswire (US) • 05/18/2026 10:50:00 AM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 05/13/2026 09:19:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 08:30:54 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 05/11/2026 08:26:45 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 05/11/2026 10:02:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:26:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:25:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:04:42 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/07/2026 08:54:38 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/07/2026 08:53:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:34:32 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/07/2026 10:33:36 AM
- BD Appoints Vitor Roque Chief Financial Officer • PR Newswire (US) • 05/07/2026 10:31:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 10:30:49 AM
- BD Reports Second Quarter Fiscal 2026 Financial Results • PR Newswire (US) • 05/07/2026 10:30:00 AM
- BD and Wellstar Advance Patient Care and Safety with Medication Management Powered by AI • PR Newswire (US) • 05/05/2026 10:50:00 AM
